Latest Institutional Purchases of Inozyme Pharma, Inc. (INZY)
This list provides information on the latest institutional transactions involving Inozyme Pharma, Inc. (INZY) stock that were buys. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the purchase has occurred.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 12, 2023
Q1 2023
|
Hrt Financial LP
New York, NY |
BUY
|
- |
45.1KNew |
$58.6K - $259K
|
45.1K
$132K
|
|
May 15, 2023
Q1 2023
|
Man Group PLC
London, X0 |
BUY
|
- |
23.9KNew |
$31.1K - $137K
|
23.9K
$70.1K
|
|
May 15, 2023
Q1 2023
|
Verition Fund Management LLC
Greenwich, CT |
BUY
|
- |
23.9KNew |
$31.1K - $137K
|
23.9K
$70K
|
|
May 15, 2023
Q1 2023
|
Point72 Middle East Fze
Stamford, CT |
BUY
|
- |
1.9KNew |
$2.47K - $10.9K
|
1.9K
$5.56K
|
|
Q4 2022 | |||||||
Feb 13, 2023
Q4 2022
|
Overbrook Management Corp
New York, NY |
BUY
|
- |
150K+ 216.37% |
$158K - $423K
|
219K
$643K
|
|
Q2 2022 | |||||||
Aug 12, 2022
Q2 2022
|
Ergoteles LLC
New York, NY |
BUY
|
- |
25.6KNew |
$82.1K - $153K
|
25.6K
$75.2K
|
|
Aug 02, 2022
Q2 2022
|
Crewe Advisors LLC
|
BUY
|
- |
163New |
$522 - $971
|
163
$478
|
|
Jul 18, 2022
Q2 2022
|
Ellevest, Inc.
|
BUY
|
- |
38+ 100.0% |
$122 - $226
|
76
$223
|
|
Aug 12, 2022
Q2 2022
|
Credit Suisse Ag
Zurich, V8 |
BUY
|
- |
8New |
$25.6 - $47.7
|
8
$23.4
|